View the METRONIDAZOLE registration information details.
Back to drug list
ItemsDrug Registration information
ID2597
No2597
Brand NameMETRONIDAZOLE
IngredientsMETRONIDAZOLE 250 MG
Dosage FormTABLET
Primary PackagingBLISTERPACK
Storage
Shelf Life3 YEARS
Pack Size10 TABS/BLIST., 50 BLISTS/BOX
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsUSED IN THE TREATMENT OF INTESTINAL AND PARENTERAL AMEBIASIS (SUCH AS AMEBIC LIVER ABSCESS AND PLEURAL AMEBIASIS). IT ALSO USED IN THE TREATMENT OF TRICHOMONAS VAGINALIS, BALANTIDIASIS AND CUTANEOUS LEISHMANOID, FILARIA MEDINENSIS INFECTION AND ANAEROBE INFECTION
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionA WHITE UNCOATED TABLET
Note
License OwnerVIENGCHALEUN PHARMA IMPORT-EXPORT COMPANY
ManufacturerZHANGFENG PHARMACEUTICAL FACTORY
CountryCHINA
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No12 I 2679/05
FDD Registration Date28/04/2023
Expiry Date27/04/2026
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA